🇺🇸 FDA
Patent

US 8497307

Aryl guanidine F1F0-ATPase inhibitors and related methods

granted A61KA61K31/40A61K31/70

Quick answer

US patent 8497307 (Aryl guanidine F1F0-ATPase inhibitors and related methods) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/40, A61K31/70, A61P, A61P1/04